tipifarnib has been researched along with gsk690693 in 2 studies
Studies (tipifarnib) | Trials (tipifarnib) | Recent Studies (post-2010) (tipifarnib) | Studies (gsk690693) | Trials (gsk690693) | Recent Studies (post-2010) (gsk690693) |
---|---|---|---|---|---|
309 | 92 | 94 | 52 | 0 | 41 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
Babic, T; Buric, SS; Dinic, J; Hadzic, S; Pesic, M; Radojkovic, D; Rankov, AD | 1 |
2 other study(ies) available for tipifarnib and gsk690693
Article | Year |
---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Comparative toxicity evaluation of targeted anticancer therapeutics in embryonic zebrafish and sea urchin models.
Topics: Abnormalities, Drug-Induced; Animals; Antineoplastic Agents; Arbacia; Benzamides; Cell Proliferation; Dose-Response Relationship, Drug; Embryonic Development; Enzyme Inhibitors; Molecular Targeted Therapy; Morpholines; Oxadiazoles; Pyrimidines; Quinolones; Signal Transduction; Wortmannin; Zebrafish | 2018 |